PharmGKB Blog
Friday, February 19, 2021

PharmGKB and CPIC curated information displayed on ClinGen

›
PharmGKB and CPIC partnered with ClinGen last summer  to bring curated pharmacogenomics (PGx) to the resource which defines the clinical ...
Thursday, February 18, 2021

Plavix manufacturers to pay $834 million to state of Hawaii

›
Bristol-Myers Squibb Co and Sanofi, the manufacturers of Plavix (clopidogrel) have been ordered to pay over $834 million to the state of Haw...
Tuesday, February 16, 2021

HGVS annotations now available on PharmVar

›
We are excited to share that PharmVar is now providing HGVS annotations in addition to their more traditional annotations. To accommodate d...
Wednesday, February 10, 2021

Update to FDA-approved drug label annotations

›
In February 2020, we blogged about the FDA's newly released Table of Pharmacogenetic Associations . Since then, there has been much int...
Wednesday, January 20, 2021

CYP2B6 GeneFocus paper published

›
The latest paper in the PharmVar GeneFocus series, looking at CYP2B6, has now been published in Clinical Pharmacology and Therapeutics . CYP...
Thursday, January 14, 2021

CPIC opioids guideline now annotated on PharmGKB

›
The CPIC guideline for opioid therapy and CYP2D6 , OPRM1 and COMT was recently published in Clinical Pharmacology and Therapeutics and ha...
Thursday, January 7, 2021

New PharmGKB pathway for Cannabidiol Pharmacokinetics

›
PharmGKB released a new pharmacokinetics pathway for Cannabidiol , a phytocannabionoid found in the Cannabis sativa plant approved to treat ...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.